StockWatch
·
Pesticides & Agrochemicals
Management Change30 Sept 2026, 11:15 am

Mahamaya Lifesciences Appoints New Directors, Re-designsates MD to Chairman

AI Summary

Mahamaya Lifesciences Ltd announced significant board changes following a meeting on September 29, 2026. Dr. Bhagirath Choudhary has been appointed as an Independent Director, transitioning from Additional Director for a three-year term starting August 25, 2026. Dr. Gopal Krishna Raju and Dr. Charudatta Digambar Mayee have been re-appointed as Independent Directors for their second three-year terms, effective December 11, 2026. Additionally, Mr. Krishnamurthy Ganesan has been re-designated from Managing Director to Chairman, effective November 1, 2026. Mr. Prashant Krishnamurthy has been re-designated as Managing Director, not liable to retire by rotation, also effective November 1, 2026. These changes were approved by the company's members based on recommendations from the Board and the Nomination and Remuneration Committee.

Key Highlights

  • Dr. Bhagirath Choudhary appointed Independent Director.
  • Dr. Gopal Krishna Raju and Dr. Charudatta Mayee re-appointed.
  • Mr. Krishnamurthy Ganesan moves from MD to Chairman.
  • Mr. Prashant Krishnamurthy appointed as new Managing Director.
  • Appointments and re-designations are effective from August/November/December 2026.